Users

Lithium Monitoring

Description

If the patient is between 45 y and 75 y of age, diagnosed with any of the diseases with code icd9:2967, and taking any drugs with code atc:N05AN01, then consider the following:

• Recommendation: Lithium Monitoring Baseline: TSH, Calcium, CBC diff, electrolytes, BUN/SCr, ECG (if older than 45 or CVD) Follow-up: Q6mo: TSH, CBC diff, electrolytes, BUN/SCr, Lithium level: Q2yr: Calcium Q5yr: ECG (if older than 45 or CVD) Drug Levels (bipolar disorder): 5 days after starting then weekly for 2 weeks then every 6 months or when new drug initiated.

Evidence

IA

Significance

Moderate

Conditions

• Age -- All: 45 y - 75 y
• Dxcodes -- Any: icd9:2967
• Drugs -- Any: atc:N05AN01

Consequence

1. Warning
   Strength: Recommendation
   Text: Lithium monitoring baseline: tsh, calcium, cbc diff, electrolytes, bun/scr, ecg (if older than 45 or cvd) follow-up: q6mo: tsh, cbc diff, electrolytes, bun/scr, lithium level: q2yr: calcium q5yr: ecg (if older than 45 or cvd) drug levels (bipolar disorder): 5 days after starting then weekly for 2 weeks then every 6 months or when new drug initiated.

Other Versions

1. Lithium Monitoring

   (Updated: 2010-03-24 13:49:29 UTC)

2. Lithium Monitoring

   (Updated: 2010-03-24 14:25:07 UTC)

3. Lithium Monitoring

   (Updated: 2010-03-24 15:13:45 UTC)

4. Lithium Monitoring

   (Updated: 2010-03-24 15:50:19 UTC)